Showing results (1-10 of 41) with videos related to
Sort By:
Pageof 5
Cancer Research|November 1, 1986
Mechanism of action of a new antitumor agent, carbetimerB Ardalan, G E PagetCancer|April 15, 1995
A new complication of chemotherapy administered via permanent indwelling central venous catheterB Ardalan, M R FloresJournal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 1, 1988
A randomized phase I and II study of short-term infusion of high-dose fluorouracil with or without N-(phosphonacetyl)-L-aspartic acid in patients with advanced pancreatic and colorectal cancersB Ardalan, G Singh, H SilbermanCancer Chemotherapy and Pharmacology|January 1, 1988
Studies on the mechanism of 3-deazaguanine cytotoxicity in L1210-sensitive and -resistant cell linesG Singh, M K Luna, B ArdalanCancer Chemotherapy and Pharmacology|January 1, 1985
Biochemical mechanisms for the scheduled synergism of (alpha S, 5S)-2 amino-3-chloro-4,5-dihydro-5-isoxazoleacetic acid and 5-fluorouracil in P388 leukemiaB Ardalan, B Chandrasekaran, H J HrishikeshavanCancer Research|April 1, 1983
Collateral sensitivity to N-(phosphonacetyl)-L-aspartic acid in a line of P388 leukemia cells selected for resistance to L-(alpha S, 5S)-alpha-amino-3- chloro-4,5-dihydro-5-isoxazoleacetic acid (acivicin)B Ardalan, H N Jayaram, R K JohnsonCancer Treatment Reports|December 1, 1986
Phase I study of recombinant beta ser 17 interferon in the treatment of cancerG Sarna, M Pertcheck, R Figlin, et al.The British Journal of Dermatology|September 1, 1975
Unusual cutaneous associations of a malignant carcinoid tumour of the bronchus--erythema annulare centrifugum and white banding of the toe nailsJ D Everall, P M Dowd, B ArdalanCancer Treatment Reports|May 1, 1981
Radiometric enzyme-inhibition technique for measuring acivicin in plasmaH N Jayaram, T W Kensler, B ArdalanCancer Investigation|May 20, 1998
Biomodulation of Fluorouracil in colorectal cancerB Ardalan, R Luis, M Jaime, et al.Pageof 5